摘要
本标准的制定旨在规范各级医疗机构对2型糖尿病合并心血管疾病患者,尤其是冠状动脉粥样硬化性心脏病和心力衰竭患者的诊疗行为,以期提高我国2型糖尿病合并心血管疾病的整体诊治水平,进而改善2型糖尿病心血管疾病的转归和结局。
This standard is established to normalize the diagnosis and treatment behavior of medical institutions at all levels for patients with type 2 diabetes complicated with cardiovascular disease,especially patients with coronary atherosclerotic heart disease and heart failure,in order to improve the overall diagnosis and treatment level as well as prognosis and outcome of type 2 diabetes complicated with cardiovascular disease in China.
作者
中国内分泌代谢病专科联盟
宁光
朱大龙
姬秋和
李玲
母义明
China Endocrinology and Metabolism Specialist Alliance;Ning Guang;Zhu Dalong(不详;Department of Endocrine and Metabolic Diseases,Shanghai Rujin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Department of Endocrinology,Nanjing Drum Tower Hospital Afiliated to Medical School of Nanjing University,Nanjing 210008,China)
出处
《中华内分泌代谢杂志》
CAS
CSCD
北大核心
2022年第10期839-842,共4页
Chinese Journal of Endocrinology and Metabolism
关键词
糖尿病
2型
心血管疾病
诊断
治疗
行业标准
Diabetes mellitus,type 2
Cardiovascular disease
Diagnosis
Treatment
Standard
